Publicacións en colaboración con investigadores/as de Institut d'Investigacions Biomèdiques August Pi i Sunyer (17)

2024

  1. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32

2023

  1. Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review

    Respiratory Medicine, Vol. 214

  2. Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 11, pp. 3407-3413.e1

  3. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288

  4. Exacerbations in COPD: a personalised approach to care

    The Lancet Respiratory Medicine

  5. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  6. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti–IL-5 Biologics: A Real-Life Study

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 1, pp. 37-44

  7. Reply to “Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies”

    Journal of Investigational Allergology and Clinical Immunology

  8. Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 214-217

2022

  1. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

    European Respiratory Journal

  2. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

  3. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases

    Archivos de Bronconeumologia, Vol. 58, pp. 39-50

2021

  1. Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 1, pp. 487-489.e1

2019

  1. A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 4, pp. 1214-1221.e3

2014

  1. Evaluation of the persistence of functional and biological respiratory health effects in clean-up workers 6years after the Prestige oil spill

    Environment International, Vol. 62, pp. 72-77

2012

  1. Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches

    Journal of Asthma, Vol. 49, Núm. 4, pp. 416-422

2009

  1. Fe de errores de "Implicación de la alteración en la regulación de la ciclooxigenasa-2 sobre la formación de miofibroblastos en la fibrogénesis pulmonar"

    Archivos de Bronconeumologia